Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
inactivated influenza vaccine (1 trial)
abacavir (ziagen) (1 trial)
bictegravir (Biktarvy) (1 trial)
dolutegravir (tivicay) (2 trials)
emtricitabine (emtriva) (1 trial)
lamivudine (epivir) (2 trials)
tenofovir alafenamide (genvoya) (1 trial)
bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine (1 trial)
daratumumab (darzalex) (1 trial)
sargramostim (leukine) (1 trial)
tremelimumab (Imjudo) (2 trials)
alpha-lactalbumin (1 trial)
fructo-oligosaccharide (1 trial)
inulin (1 trial)
sodium butyrate (1 trial)
zinc oxide (1 trial)
Influenza, Human (Phase 4)
Leukemia (Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)
Leukemia, Myeloid (Phase 2)
Lung Neoplasms (Phase 2)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (8 total)
Trial APIs (16 total)